Center for drug evaluation and research (cder), center for biologics evaluation and research (cber), pharmacovigilance system implementation and IT lifecycle support for FDA adverse event reporting…

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75F40120D00009
Awardee
Awarding agency
Task orders
4 $24,810,413 obligated

Award facts

Opportunity
  • 1223394 Solicitation number
Combined order value
  • $24,810,413 Current, with exercised options
  • $26,492,257 Potential, with all options
Last date to order 100% complete
IDV ceiling 99% used
$25,000,000.00
Maximum order
$25,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
8(a) Sole Source
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Chickasaw Strategic Pointe, LLC with a potential value of $25 million to provide pharmacovigilance system implementation and information technology lifecycle support for the Adverse Event Reporting System II program. The single award contract has a period of performance through March 2024.

Under this contract, four firm fixed price delivery orders have been awarded to Chickasaw Strategic Pointe totaling over $27.5 million to provide information technology operations and maintenance support, requirements development, and data administration services essential to the FDA's post-market safety surveillance efforts. Services have been performed in Arkansas, Oklahoma, Maryland, and Maryland by the prime contractor. No subcontracting or set aside details were indicated in the materials provided. The delivery orders aim to ensure the FDA can effectively monitor safety issues with medical products through analysis of adverse event reports submitted to its Adverse Event Reporting System II.

Description

Center for drug evaluation and research (cder), center for biologics evaluation and research (cber), pharmacovigilance system implementation and IT lifecycle support for FDA adverse event reporting system (faers) II program

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75F40120D00009?

75F40120D00009 was awarded to Chickasaw Strategic Pointe, LLC by Food and Drug Administration (Department of Health and Human Services) on March 25, 2020.

How much is contract 75F40120D00009 worth?

Orders under 75F40120D00009 have obligated $24,810,413. Their combined current value, with exercised options, is $24,810,413. Their combined potential value, with all options, is $26,492,257. 75F40120D00009's own ceiling is $25,000,000. A single order can be worth up to $25,000,000.

How many orders have been placed under contract 75F40120D00009?

4 orders have been placed under 75F40120D00009, the latest on April 12, 2022.

Who can order from contract 75F40120D00009?

75F40120D00009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75F40120D00009 competed?

The extent of competition for 75F40120D00009 was not available for competition. The government received 1 offer. It was set aside: 8(a) Sole Source.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV